Trump’s losses in drug pricing battle should be a free market wake-up call to him

CNBC News

11 July 2019 - The Trump administration lost two key battles in the span of 48 hours in its fight to get prescription drug prices down. But it can still win the war by getting back to its free market roots.

The Trump administration lost two key battles in the span of 48 hours in its fight to get prescription drug prices down. But it can still win the war by getting back to its free market roots.

Earlier this week, a federal court nixed the Trump team’s plan to force prescription drug companies to publish drug prices in their advertising.

Then on Thursday morning, the administration backed down from it push to eliminate prescription drug rebates after concerns grew that killing the rebates would adversely affect senior citizens.

Read CNBC News article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing